AI-CVD vs IM007
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, AI-CVD, focuses on opportunistic screening for cardiovascular diseases by analyzing existing CT scans to identify hidden health risks through quantitative imaging. In contrast, Tool B, IM007, is an AI-powered platform for remote cardiac monitoring, aggregating data from cardiac implantable electronic devices to streamline workflows and manage alerts. While both operate in the cardiology AI space, they address different clinical needs: diagnostic imaging analysis versus ongoing patient device management.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
AI-CVD is an AI-powered quantitative imaging platform designed for opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. In contrast, IM007 is an AI-powered, cloud-based platform for remote cardiac monitoring, aggregating data from all cardiac implantable electronic devices (CIEDs) to streamline workflows, reduce false alerts, and improve patient outcomes in cardiology and heart failure management.
AI-CVD utilizes existing chest and abdominal CT scans for opportunistic screening, making it suitable for patients undergoing CT scans for various reasons. IM007 aggregates data from cardiac implantable electronic devices (CIEDs) from multiple manufacturers, specifically targeting patients with these devices for remote monitoring.
AI-CVD performs opportunistic screening from existing CT scans without requiring additional imaging, radiation, contrast, or workflow disruption. IM007 streamlines remote cardiac monitoring workflows, reduces false positives in alerts (e.g., 79% for ILR ECG Analyzer, 85% for AF alerts), and offers smart workflow automation for tasks like billing, reporting, and scheduling, along with EHR integration capabilities.
AI-CVD offers automated CT-derived anatomical and density-based measurements, including Coronary Artery Calcium (CAC) scoring, aortic and mitral valve calcium analysis, cardiac chamber volumetry, epicardial fat volumetry, and aorta and pulmonary artery sizing. IM007 features AI-driven alert management, an FDA-cleared ILR ECG Analyzer for ICM ECG data analysis, and SignalHF, an FDA-cleared predictive AI for heart failure hospitalization risk.
AI-CVD is designed for use across Cardiology, Pulmonology, and Radiology specialties, focusing on imaging-based opportunistic screening. IM007 primarily serves Cardiology and Hospital Medicine, focusing on the management of patients with cardiac implantable electronic devices through remote monitoring.